King Wealth Management Group’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
King Wealth Management Group's NVS Position: Q2 2026 in Review
King Wealth Management Group increased its Novartis (NVS) stake by 1.6% in Q2 2026, buying an estimated $7.65K and bringing the position to 3,251 shares worth $509K. The position accounts for 0.06% of the portfolio, ranked #110.
King Wealth Management Group first reported a position in NVS in Q3 2019 and has held it in 18 quarters since. The position peaked at $1.22M in Q2 2020. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- King Wealth Management Group held 3,251 shares of Novartis worth $509K as of Q2 2026.
- King Wealth Management Group bought 51 Novartis shares in Q2 2026, an estimated $7.65K.
- Novartis made up 0.06% of King Wealth Management Group's portfolio in Q2 2026, its #110 holding.
- King Wealth Management Group first reported a position in Novartis in Q3 2019 and has held it in 18 quarters since.
- King Wealth Management Group's Novartis position peaked at $1.22M in Q2 2020.
- 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on King Wealth Management Group's 13F filing for Q2 2026, filed 5 Aug 2026.